Presentation is loading. Please wait.

Presentation is loading. Please wait.

Discussing Clinical & Business Tools Useful for Implementing Integrative Therapies, Programs, and Products into Clinical Practice. [Sanesco Logo]

Similar presentations


Presentation on theme: "Discussing Clinical & Business Tools Useful for Implementing Integrative Therapies, Programs, and Products into Clinical Practice. [Sanesco Logo]"— Presentation transcript:

1 Discussing Clinical & Business Tools Useful for Implementing Integrative Therapies, Programs, and Products into Clinical Practice. [Sanesco Logo]

2 Why do we care? Why I started on this path – my patient
Patient-Driven Movement Continual patient requests for various treatments such as GI allergy testing – yeast, food sensitivities, etc, BHRT and neurotransmitter testing years ago before it was really on the radar Ability to assess and treat continued symptoms despite usual and customary treatment options [happy patient image]

3 Where do we start? Open mindedness – thinking outside the box from customary treatment options, Respecting and researching other disciplines – their treatments, research, etc General points of where to begin What mindset to be in Introduction of where to start

4 Connected to the Global Integrative Medical Movement
Medical Journals Medical Periodicals Health Blogs The Natural Standard Consumerlab.com Integrative Medical Journal [consumberlab.com logo & The Natural Standard logo] [smaller integrative & alternative medical journal articles]

5 Strategies for the Generalist
Key points on how to go through the junk Prove themselves from financial and clinical operational perspectives. Luminary clinical skills are not enough to guarantee the survival of such programs--a strong clinical base of expertise in alternative therapies is a key success factor No substitutes for clinical excellence or sound management Much of the buzz over integrative medicine is well deserved. The opportunities seem to outweigh the risks, but superior management skills are needed to guide these programs through adolescence into clinical and business maturity. By carefully considering the staffing, team building, compensation methods, marketing, and program evaluation and development issues explored in this article, health care and physician executives should be able to steer between the rocks on their way to integrative medicine decisions that are right for their organizations. Physician Exec Nov-Dec;24(6):22-5.Complementary and alternative medicine. Integrative medicine: business risks and opportunities.Berndtson K.SourceAmerican WholeHealth, Inc., USA.

6 Colleague Validation & Clinical Practice Success
Look towards active opinion leaders Active peers showing clinical & business success Other larger health organization finding clinical success – Shadowing some who’s using what is in question When researching potential additions to current treatments/testing, consider calling the company to inquire into area providers involved in similar treatment – not only individual providers but practices Local or long distance When reviewing research articles – note authosr, bibliography, - google authors, clinics cited in research Shadowing is a powerful experience – overview of patient interaction, ideas for incorporating business/clinical model, delivery of information, etc [group of doctors and healthcare practitioners image]

7 Looking at the Scientific Evidence
Bio-idential hormone program Several labs offering blood and saliva besides convention labs such as LabCorp, Quest, etc Thought process – speaking with company representatives, gathering list of area clinicians and speaking with them, attending conferences – CME available - also very interesting as usual and customary subject matter is presented in another manner with other approaches for treatment The study below, published in 2002 outlines the sentiment that there isn’t enough scientific evidence to prove unconventional therapies effective. While as a clinician, there is a positive tendency to favor clinical evidence and acceptance of peers in active practice because seeing is believing. This slide can be dedicated to your own experience with ‘non-believers’. Purpose: The number of U.S. medical schools offering courses in complementary and alternative medicine (CAM) has risen sharply in recent years. This study gauged the current state of CAM instruction by gathering details about the specific topics being taught and the objectives behind the instruction.Method: Data were collected from questionnaires mailed to 123 CAM course directors at 74 U.S. medical schools.Results: Questionnaires were returned by 73 course directors at 53 schools. The topics most often being taught were acupuncture (76.7%), herbs and botanicals (69.9%), meditation and relaxation (65.8%), spirituality/faith/prayer (64.4%), chiropractic (60.3%), homeopathy (57.5%), and nutrition and diets (50.7%). The amounts of instructional time devoted to individual CAM topics varied widely, but most received about two contact hours. The “typical” CAM course was sponsored by a clinical department as an elective, was most likely to be taught in the first or fourth year of medical school, and had fewer than 20 contact hours of instruction. Most of the courses (78.1%) were taught by individuals identified as being CAM practitioners or prescribes of CAM therapies. Few of the courses (17.8%) emphasized a scientific approach to the evaluation of CAM effectiveness.Conclusion: A wide variety of topics are being taught in U.S. medical schools under the umbrella of CAM. For the most part, the instruction appears to be founded on the assumption that unconventional therapies are effective, but little scientific evidence is offered. This approach is questionable, especially since mainstream medicine owes much of its success to a foundation of established scientific principles Academic Medicine:September Volume 77 - Issue 9 - p 876–881Special Theme: Complementary, Alternative, and Integrative Medicine: SPECIAL THEME RESEARCH REPORTSThe Teaching of Complementary and Alternative Medicine in U.S. Medical Schools: A Survey of Course DirectorsBrokaw, James J. PhD, MPH; Tunnicliff, Godfrey PhD; Raess, Beat U. PhD; Saxon, Dale W. PhD

8 Case Study: How Sanesco Presented the Scientific & Clinical Evidence
Urinary Neurotransmitter Testing White Paper – R.W. Watkins, MD, MPH Statistical Clinical Reports Practitioner Case Studies – from active and accredited members in our network. Consolidated Medical References Hundreds and Thousands of Patients Tested [images of training and education pieces]

9 Quality & Technology

10 Case Study: Key Highlights in Sanesco and NeuroLab’s Quality & Technology Really makes a difference!
Regulatory certifications Enrollment in proficiency testing programs Internal Quality Control tracking Laboratory technology platform for optimum precision and accuracy; minimum room for human error Regularly undergoes validation studies Laboratory Quality: CLIA accredited, best in industry clinical analysis technology, third-party verification programs -

11 How do I choose between clinical product and service providers
Scientific Evidence and Clinical Success Observations Education & Training Business Implementation & Personal Support On-Demand or Fast Clinical/Product Support Patient Accessibililty Financial Bottom Line

12 Education & Training NEUROENDOCRINE CLINCAL ANALYSIS PROGRAM (NCAP)
ONE-ON-ONE SUPPORT AND INTERPRETATIONS MEDICAL BOARD CONSULTS ONLINE EDUCATIONAL MODULES PATIENT TESTING AND NATURAL PRODUCTS PACKAGES [training program images]

13 Implementation Made Easy
Easy phone call to Sanesco provided exceptional customer service, clear and concise information on the process, on-going communication Sanesco team member was very informative, kept practitioner on schedule for timely certification, outstanding record keeping, “lots of hand holding”! Time involved – several one hour webinars, a session or two with clinical support to learn integration of model, with interpretation of several tests – probably 2 months of intermittent training but could be much less Sanesco team is dedicated to training all necessary staff members to thoroughly understand the model Everyone at Sanesco is very easy to access and the follow up is outstanding

14 Patient Accessibility
Cost Insurance Testing and Treatment Options Cost: affordable – with special pricing under certain circumstances Insurance: Medicare, and most insurance plans Options: see above [patient image] Will update with the important of cost and options scholarly article published in the last couple of years.

15 Financial Impacts to the Practice
Improve revenue Patient retention Broaden patient reach Improve bottom-line

16 Sanesco Example My Experience with CSM as an Integrative Program in my Practice Most patients presenting for another concern have symptoms of neurotransmitter imbalances Identification of potential imbalances with testing and treatment is intriguing to patients. Many have been over medicated and under diagnosed leading to frustration and decreased quality of life Pt satisfaction is very high and they are appreciative of “new and different” treatment options Not only do you have referrals from area providers but from patients. Many refer their sons, daughters, mother’s, spouses etc. Referral of a family member t is the highest compliant given by a patient Ongoing revenue stream – additional 10-15% added to net revenue from office visits Referrals from all areas of health care specialties as symptoms are present in all cultures, ages, sex, etc

17 Laboratory Quality: What to Look For
Regulatory certifications Enrollment in proficiency testing programs Internal Quality Control tracking Laboratory technology platform for optimum precision and accuracy; minimum room for human error Regularly undergoes validation studies

18 Service Provider / Strategic Partner: What to look for
Clinical experience: tens of thousands of patients tested Proven clinical outcome Leadership: credentials of the multidisciplinary Clinical Advisory Board Technology and innovation Service, responsiveness, and technical expertise Patient-friendly, user-friendly Ease of implementation

19 Clinical Success Factors
Targeted Nutritional Therapy NSB + quality ingredient sources and active forms + scientifically proven combinations of cofactors = lower concentration of main ingredients, fewer capsules per day, improved patient compliance, reduced overall treatment period, well protected investment for patients, optimal clinical outcome Correlation Analysis Report Patient-specific and comprehensive Reveals key links between biochemical imbalances and patient symptoms Easy to understand by synthesizing interpretation Allows effective treatment of a wider spectrum of cases allowing you to refer less patients Suggests easy to follow therapeutic protocols For a graphical TNT example, we should display 3 TNT bottles on the left and list the number of recommended capsules per day; and on the right, display all the different supplement bottles that would be needed to obtain the ingredients included in the 3 TNT formulas and list the number of capsules needed per day to match the TNT protocol.

20 Financial Success Factors
More patient visits and meaningful interaction The serial testing model and necessary adjustment of therapeutic protocols provides more selling opportunities Boutique-type of service serving your local area Applicable model to all patients: Prevention Wellness Chronic symptoms and conditions For “financial success factors” we can display the piece that demonstrates the revenue model and potential net profit.

21 Professional Success Factors
Training and education programs Learning to apply one of the most innovative, sophisticated, and clinically effective tools in the market today Join the hundreds of practitioners who have already experienced the benefits for their practice and their patients Access to Sanesco’s esteemed multidisciplinary Clinical Advisory Board


Download ppt "Discussing Clinical & Business Tools Useful for Implementing Integrative Therapies, Programs, and Products into Clinical Practice. [Sanesco Logo]"

Similar presentations


Ads by Google